Contents
Download PDF
pdf Download XML
517 Views
78 Downloads
Share this article
Research Article | Volume 2 Issue 1 (, 2012) | Pages 11 - 20
Serum Total Homocysteine Level: A True Cardiovascular: Risk Factor or an Acute Phase Reactant Protein?
Under a Creative Commons license
Open Access
Published
March 23, 2012
Abstract
Atherosclerosis is the leading cause of death in the developed world1.In Pakistan; the disease seems to follow an accelerated course with ischaemic events occurring a decade earlier than those reported worldwide2. While many risk factors of cardiovascular diseases are well established, many are still under evaluation; like homocysteine, which is now being considered an independent risk factor for cardiovascular diseases3. Homocysteine is a sulfur containing amino acid which is not our dietary constituent but is formed by metabolism of methionine, another amino acid present in our daily protein diet. In case of excess formation of homocysteine as compared to its consumption, it appears in urine if levels are too high3. Normal plasma homocysteine concentration ranges from 5 to 15µmol/litre. Of this, almost 75% is bound to proteins, especially albumin, through disulfide bond. Classification of hyperhomo- cysteinemia described by Kang SS 4 is followed widely. Moderate hyperhomocysteinemia (15 to 30 µmol/litre) Intermediate hyperhomocysteinemia (30 to 100µmol/litre) Severe hyperhomocysteinemia (>100 µmol/litre)
Keywords
Recommended Articles
Research Article
RARE PRESENTATION OF CARDIAC HEMANGIOMA – ACUTE CORONARY SYNDORME
Published: 18/05/2026
Download PDF
Research Article
Comparative study of laparoscopic cholecystectomy with and without drains
Published: 29/07/2011
Download PDF
Research Article
A Prospective Randomised Controlled Study Comparing Clinical Effects of Intraoperative Dexmedetomidine with Ketamine or Fentanyl as Adjuvants during General Anaesthesia
Published: 15/05/2026
Download PDF
Research Article
“ULTRASOUND GUIDED FEMORO-SCIATIC NERVE BLOCK FOR LOWER LIMB SURGERIES: COMPARISON BETWEEN CLONIDINE AND DEXMEDETOMIDINE WITH LEVOBUPIVACAINE”
Published: 15/05/2026
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.